Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
1928 Diagnostics logo — 1928 Diagnostics fights antibiotic resistance through DNA an...

1928 Diagnostics

1928 Diagnostics fights antibiotic resistance through DNA analysis, offering outbreak tracing and infection control services.

Founded 2014 Sweden Sweden Venture round Total: $8.35M Biotechnology, Health Care

General Information

Company Name 1928 Diagnostics
Founded Year 2014
Location Sweden Sweden
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with 1928 Diagnostics. To contact 1928 Diagnostics, visit 1928diagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 1928 Diagnostics compare?

A PDF of 1928 Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 1928 Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 1928 Diagnostics

1928 Diagnostics is a biotechnology startup founded in 2014 and headquartered in Sweden. The company's slogan, "1928 Diagnostics fights antibiotic resistance through DNA analysis, offering outbreak tracing and infection control services," encapsulates its mission to combat antibiotic resistance through DNA analytics. Their innovative digital health solutions empower healthcare providers with outbreak tracing and diagnostics, ensuring complete infection control within hospitals. The founders, including scientists and entrepreneurs in the tech and healthcare industries, are united in the fight against antibiotic resistance, one of humanity's biggest threats. In July 2018, the company secured a $1.50M Venture Round investment to further their efforts in addressing antibiotic resistance. This funding signifies investor confidence in 1928 Diagnostics' pioneering approach to tackle this pressing global health concern. As the threat of antibiotic resistance continues to escalate, 1928 Diagnostics stands at the forefront, leveraging DNA analysis and digital solutions to make a meaningful impact in the battle against this critical issue.

Business keywords: DNA analysis, antibiotic resistance, outbreak tracing, infection control services, digital health solutions, medical diagnostics

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.50M -
03 Jul 2018
Seed Round €2.10M 1
Sciety
04 May 2017
Angel Round $2.20M -
06 Apr 2017
Seed Round $2.50M -
02 Jan 2017
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Dec 2015

1928 Diagnostics Alternatives & Competitors

View All Alternatives
1928 Diagnostics vs
Genomtec SA
Genomtec SA Poland

Molecular diagnosis everywhere, at the right time and for the right price.

Grant
26 employees
Biotechnology, Health Care
1928 Diagnostics vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
1928 Diagnostics vs
Felix Biotechnology
Felix Biotechnology

Pioneering the future of infection management with precision-targeted biotherapeutics to combat anti...

Grant
Biopharma, Biotechnology
View all alternatives

FAQ About 1928 Diagnostics

1928 Diagnostics fights antibiotic resistance through DNA analysis, offering outbreak tracing and infection control services.
1928 Diagnostics was founded in 2014.
1928 Diagnostics is headquartered in Sweden.
1928 Diagnostics operates in Biotechnology and Health Care. Its work centres on DNA analysis, antibiotic resistance, outbreak tracing and infection control services.
1928 Diagnostics has completed 5 funding rounds, raising a total of $8.35M. The latest funding stage is Venture round.
Top alternatives and competitors to 1928 Diagnostics include Genomtec SA, EMPE Diagnostics, Felix Biotechnology, Gedea Biotech AB, Microplate Dx Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
1928 Diagnostics and Genomtec SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 1928 Diagnostics, https://bouncewatch.com/company/1928-diagnostics, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout